Compare Citra Nusantara Gemilang Tbk. (CGAS) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citra Nusantara Gemilang Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp154 (market cap 262.18B, 10.35M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Citra Nusantara Gemilang Tbk. is more actively traded (10.35M versus 963.6K). Which is the better fit depends on your goals.
| CGAS | DGNS | |
|---|---|---|
Market Cap | 262.18B | 310.75B |
Volume | 10.35M | 963.6K |
Lot | 103.48K | 9.64K |
Turnover | 1.6B | 217.67M |
Average Price | 154.22 | 225.89 |
Value | 1.6B | 217.67M |
Indicative Equilibrium Price | 154 | 226 |
Indicative Equilibrium Volume | 2.6K | 1K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citra Nusantara Gemilang Tbk.
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
